Sangel Capital is one of the earliest established healthcare venture capital firms in China. Deliciated to novel technologies and healthcare innovation, the firm focuses on investing in startups in biotech, biopharma, medical devices, and digital health.
Sangel capital identifies particularly promising startups that can achieve high return, and helps the portfolio to grow to their full potential. With headquarters in Shenzhen, Sangel Capital has offices in Beijing, Suzhou, and the US.
Sangel’s team has a broad range of expertise, including entrepreneurs, scientists, investors and advisors. Sangel Capital has been managing a series of RMB and USD funds, and has earned multiple awards from China national organizations.